Advertisement
Enrollment in a study testing an experimental antibody therapy against COVID-19 has been paused by independent monitors.

COVID-19 Antibody Treatment Study Paused

0
ACTIV-3 study, testing use of an antibody therapy with remdesivir, paused 'out of an abundance of caution'
Protective antibodies persist for months in patients who survive serious COVID-19 infections

Immune Responses Long-Lasting After Serious COVID-19

0
IgG levels remain elevated for four months in patients with symptoms lasting for 14 days
Individuals with blood group O may have a reduced risk for severe acute respiratory syndrome coronavirus 2 infection

Individuals With Blood Group O Have Lower Risk for COVID-19

0
And more COVID-19 patients with blood group A or AB require mechanical ventilation, CRRT
Current angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with a slightly lower mortality risk in patients hospitalized with influenza or pneumonia

Certain HTN Meds May Cut Deaths From Influenza, Pneumonia

0
Use of ACE-I/ARB versus nonuse linked to lower mortality for those hospitalized with flu, pneumonia
Delivering web-based vaccine messages tailored to parents' vaccine beliefs and values does not improve uptake of infant vaccinations

Web-Based Tailored Messages Do Not Increase Infant Vaccination Rates

0
No increase seen in timely uptake by parents who receive messages tailored to vaccine beliefs, values
For patients undergoing elective cancer surgery

COVID-19-Free Surgical Pathways May Aid Cancer Surgery Outcomes

0
Pulmonary complication, postoperative SARS-CoV-2 infection rates lower with COVID-19-free pathways
The number of expected U.S. deaths increased considerably from March through July 2020

U.S. Deaths Up 20 Percent From March Through July 2020

0
The United States has had high COVID-19-associated mortality compared with other countries
Hosting more than 14

Racism, Preventive Care at Forefront of American Academy of Pediatrics Conference

0
Elizabeth Murray, D.O., AAP spokesperson, discussed the highlights of this year's virtual conference with HD Live!
A second COVID-19 vaccine trial was paused on Monday after an unexplained illness surfaced in one of the trial's volunteers.

Second COVID-19 Vaccine Trial Paused for Unexplained Illness

0
Johnson & Johnson stopped its COVID-19 vaccine trial, which began phase 3 testing last month
The COVID-19 pandemic has created urgency around getting this year's flu vaccine

Survey: About 3 in 4 U.S. Adults Likely to Get Flu Shot This Season

0
One-third report they are more likely to get a flu shot this year than previously